Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N van Geel

Showing results (221-230 of 233) with videos related to

Pageof 24
Sort By:
Annals of Surgical Oncology|June 2, 2007
Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer ClinicBernadette A M Heemskerk-Gerritsen, Cecile T M Brekelmans, Marian B E Menke-Pluymers, et al.
Annals of Surgery|December 1, 1996
Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experienceA M Eggermont, H Schraffordt Koops, J M Klausner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2005
Survival and prognostic factors in BRCA1-associated breast cancerC T M Brekelmans, C Seynaeve, M Menke-Pluymers, et al.
Lancet (London, England)|July 4, 1998
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Survival in hereditary breast cancer associated with germline mutations of BRCA2L C Verhoog, C T Brekelmans, C Seynaeve, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2007
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer casesC T M Brekelmans, M M A Tilanus-Linthorst, C Seynaeve, et al.
Hereditary Cancer in Clinical Practice|April 3, 2009
Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomyMurly B M Tan, Eveline M A Bleiker, Marian B E Menke-Pluymers, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2004
Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapyC Seynaeve, L C Verhoog, L M C van de Bosch, et al.
Breast Cancer Research and Treatment|June 29, 2002
One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery)Litanja N Lodder, Petra G Frets, R Willem Trijsburg, et al.
Pigment Cell & Melanoma Research|March 16, 2012
Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus ConferenceK Ezzedine, H W Lim, T Suzuki, et al.
Pageof 24

Showing results (221-230 of 233) with videos related to

Sort By:
Pageof 24
Annals of Surgical Oncology|June 2, 2007
Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer ClinicBernadette A M Heemskerk-Gerritsen, Cecile T M Brekelmans, Marian B E Menke-Pluymers, et al.
Annals of Surgery|December 1, 1996
Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experienceA M Eggermont, H Schraffordt Koops, J M Klausner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2005
Survival and prognostic factors in BRCA1-associated breast cancerC T M Brekelmans, C Seynaeve, M Menke-Pluymers, et al.
Lancet (London, England)|July 4, 1998
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Survival in hereditary breast cancer associated with germline mutations of BRCA2L C Verhoog, C T Brekelmans, C Seynaeve, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2007
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer casesC T M Brekelmans, M M A Tilanus-Linthorst, C Seynaeve, et al.
Hereditary Cancer in Clinical Practice|April 3, 2009
Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomyMurly B M Tan, Eveline M A Bleiker, Marian B E Menke-Pluymers, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2004
Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapyC Seynaeve, L C Verhoog, L M C van de Bosch, et al.
Breast Cancer Research and Treatment|June 29, 2002
One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery)Litanja N Lodder, Petra G Frets, R Willem Trijsburg, et al.
Pigment Cell & Melanoma Research|March 16, 2012
Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus ConferenceK Ezzedine, H W Lim, T Suzuki, et al.
Pageof 24